Nörogender
October 5-6 Divan Hotel / Istanbul
#DravetSyndrome #CurrentTreatments #SCN1AGene #EpilepsyTreatment #GeneticTherapy #DrugTreatment #MultidisciplinaryApproach #Neurology #PediatricNeurology #RareDisease #Neurogenetics #Epilepsy #GeneticSyndrome #TreatmentStrategies #QualityOfLife
Prof. Dr. Burak Tatlı
Rett and Dravet Syndrome Drug Study: Current Status Important Development We want to share good news with you. The design of the genetic drug we …
Read Article
Prof. Dr. Burak Tatlı
Neurogenetic Diseases Treatment Platform: ASO-Based Treatments ASO-Based Treatments Antisense oligonucleotides (ASOs) are short, synthetic, …
Read Article